Amy Hoeper

发表

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

R. Couch, T. Cate, R. Belshe, 2007, Vaccine.

Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G

R. Frenck, M. Venkatesan, A. L. Bourgeois, 2020, mSphere.

Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G

R. Frenck, M. Venkatesan, A. L. Bourgeois, 2020 .

Safety and Immunogenicity of Escalating Dosages of a Single Oral Administration of Peru-15 pCTB, a Candidate Live, Attenuated Vaccine against Enterotoxigenic Escherichia coli and Vibrio cholerae

D. Bernstein, Wilbur H. Chen, Mitchell Cohen, 2014, Clinical and Vaccine Immunology.

Randomized, Controlled Human Challenge Study of the Safety, Immunogenicity, and Protective Efficacy of a Single Dose of Peru-15, a Live Attenuated Oral Cholera Vaccine

K. Killeen, J. Bean, David N. Taylor, 2002, Infection and Immunity.

Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G

R. Frenck, A. Fix, M. Venkatesan, 2020, mSphere.

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

Kevin S. Katen, Maureen F. Maughan, D. Bernstein, 2009, Vaccine.

A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.

R. Frenck, M. Venkatesan, W. Alexander, 2018, Vaccine.

The safety and immunogenicity of escalating dosages of a single oral administration of Peru

D. Bernstein, Wilbur H. Chen, Mitchell Cohen, 2014 .

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

Kevin S. Katen, Maureen F. Maughan, D. Bernstein, 2009, Vaccine.